Pfizer-BioNTech COVID-19 vaccine gains full U.S. regulatory approval
Go back to Pfizer-BioNTech COVID-19 vaccine gains full U.S. regulatory approval| (NASDAQ: BNTX) | Delayed: 91.22 +0.33 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.89 | 52 Week High | $ | |||
| Open | $89.89 | 52 Week Low | $ | |||
| Day High | $91.38 | P/E | N/A | |||
| Day Low | $89.71 | EPS | $ | |||
| Volume | 356,964 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.07 -0.14 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.21 | 52 Week High | $37.39 | |||
| Open | $25.22 | 52 Week Low | $28.25 | |||
| Day High | $25.31 | P/E | 15.19 | |||
| Day Low | $24.96 | EPS | $1.65 | |||
| Volume | 16,542,524 | |||||
